English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
EORTC President
Share :
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
14326
Rating:
Save
Rate video
Prof. Martine Piccart
Calls for greater cancer drug funding from governments and emphasises targeted therapy.
Categories:
Lung & pleura
Related Videos
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy...
Dr Li Zhang - Sun Yat-Sen University Cancer Centre, Guangzhou, China
9 Oct 2024
Tusamitamab ravtansine versus docetaxel in previously treated advanced...
Prof Benjamin Besse - Gustave Roussy, Paris, France
1 Oct 2024
Cemiplimab monotherapy could be a new treatment option for first line advanced...
Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia
1 Oct 2024
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
Amivantamab-lazertinib continue to show benefit as a first-line standard-of...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
TROP2 expression measured by QCS is a promising predictor of clinical outcomes...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
16 Sep 2024
Immunotherapy resistance pathways investigated to tailor combination NSCLC...
Prof Pascale Tomasini - Aix-Marseille University, Marseille, France
16 Sep 2024
Mutational-based treatment approach may significantly improve outcomes in...
Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy
16 Sep 2024
More from
e
cancer